Publication | Closed Access

Interleukin-6 and JAK2/STAT3 signaling mediate the reversion of dexamethasone resistance after dexamethasone withdrawal in 7TD1 multiple myeloma cells

InflammationDexamethasone WithdrawalCytokineHematological MalignancyAutoimmune DiseaseMalignant Blood DisorderHematologyImmunologyDexamethasone ResistanceAutoimmunityMultiple Myeloma CellsMedicineCell BiologyJak-stat Signaling Pathway